TrialThe Journal of clinical endocrinology and metabolism2024

Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).

Juan P Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.